Cargando…
Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation
BACKGROUND: The optimal timing of salvage androgen deprivation therapy (ADT) following definitive radiation therapy for prostate cancer (PCa) is unknown. This study evaluated the efficacy of early initiation of salvage-ADT (S-ADT) based on predetermined timing among patients with unfavorable PCa tre...
Autores principales: | Aizawa, Rihito, Takayama, Kenji, Nakamura, Kiyonao, Inoue, Takahiro, Yamasaki, Toshinari, Kobayashi, Takashi, Akamatsu, Shusuke, Ogawa, Osamu, Mizowaki, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736780/ https://www.ncbi.nlm.nih.gov/pubmed/31152322 http://dx.doi.org/10.1007/s10147-019-01478-y |
Ejemplares similares
-
Long-term clinical outcomes of salvage pelvic radiation therapy for oligo-recurrent pelvic lymph nodes after definitive external-beam radiation therapy for non-metastatic prostate cancer
por: Sato, Genki Edward, et al.
Publicado: (2020) -
Ten‐year outcomes of whole‐pelvic intensity‐modulated radiation therapy for prostate cancer with regional lymph node metastasis
por: Nakamura, Kiyonao, et al.
Publicado: (2022) -
Clinical significance of IDC‐P as predictive factor after intensity‐modulated radiation therapy
por: Aizawa, Rihito, et al.
Publicado: (2022) -
Radiation and Androgen Deprivation Therapy With or Without Docetaxel in the Management of Nonmetastatic Unfavorable-Risk Prostate Cancer: A Prospective Randomized Trial
por: D'Amico, Anthony V., et al.
Publicado: (2021) -
Castration-Resistant Prostate Cancer Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents: Opportunities and Challenges
por: Kita, Yuki, et al.
Publicado: (2018)